Edition:
India

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

40.00USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$40.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,670
52-wk High
$54.45
52-wk Low
$12.75

Chart for

About

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or... (more)

Overall

Beta: --
Market Cap(Mil.): $495.06
Shares Outstanding(Mil.): 30.56
Dividend: --
Yield (%): --

Financials

BRIEF-Atara Biotherapeutics Reports Q1 Loss Per Share $1.05

* ATARA BIOTHERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

08 May 2018

BRIEF-Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration

* ATARA BIOTHERAPEUTICS EXPANDS T-CELL IMMUNOTHERAPY COLLABORATION TO ADVANCE NEXT-GENERATION CAR T TECHNOLOGIES IN ONCOLOGY, AUTOIMMUNE AND OTHER DISEASES Source text for Eikon: Further company coverage:

08 May 2018

Competitors

  Price Chg
Biogen Inc (BIIB.OQ) $341.24 +2.33
Bayer AG (BAYGn.DE) €75.82 +1.79
Bayer AG (BAYE.F) -- --
Teva Pharmaceutical Industries Limited (TEVA.TA) 8,848.00 +187.00
Merck KGaA (MRCG.DE) €86.70 -0.60
Sanofi SA (SASY.PA) €74.67 -0.45
Novartis AG (NOVN.S) CHF81.94 +0.20
Roche Holding Ltd. (ROG.S) CHF235.05 -1.45
Roche Holding Ltd. (RO.S) CHF236.60 -2.00

Earnings vs. Estimates